首页> The Journal of infection> Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity.

Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity.

导出 OA

翻译打印收藏纠错

第一作者： Julien,Favresse

第一单位： Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium; Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Namur, Belgium. Electronic address: julien.favresse@slbo.be.

作者： Julien,Favresse ^[1] ; Jean-Louis,Bayart ^[2] ; Clara,David ^[3] ; Jean-Michel,Dogné ^[4] ; Jonathan,Douxfils ^[5]

作者单位： Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium; Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Namur, Belgium. Electronic address: julien.favresse@slbo.be. ^[1] Department of Laboratory Medicine, Clinique St-Pierre Ottignies, Ottignies-Louvain-la-Neuve, Belgium. ^[2] Qualiblood sa, Namur, Belgium. ^[3] Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Namur, Belgium. ^[4] Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Namur, Belgium; Qualiblood sa, Namur, Belgium. ^[5]

关键词 Antigenic assay COVID-19 RT-PCR SARS-CoV-2 disease severity

医学主题词抗体, 病毒(Antibodies, Viral);人类(Humans);核壳(Nucleocapsid);敏感性与特异性(Sensitivity and Specificity);疾病严重程度指数(Severity of Illness Index);工艺学(Technology)

DOI 10.1016/j.jinf.2022.01.023

PMID 35074508

发布时间 2022-07-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交